Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Article Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Team
    • Feedback
    • Reprints
    • Impact Factor
    • Editorial Fellowship Application Process
  • ASN Kidney News
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Article Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Team
    • Feedback
    • Reprints
    • Impact Factor
    • Editorial Fellowship Application Process
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
Up Front MattersEditorials
You have accessRestricted Access

Fatal Attraction: Immunoglobulin A and the Glomerular Mesangium

Jürgen Floege
JASN July 2019, 30 (7) 1139-1141; DOI: https://doi.org/10.1681/ASN.2019040373
Jürgen Floege
Division of Nephrology, Medizinische Klinik II, Rheinisch Westfälische Technische Hochschule University Hospital Aachen, Aachen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading
  • IgA nephropathy
  • proteinuria
  • Progression
  • GFR loss
  • Innate immunity
  • Affinity maturation

The defining feature of IgA nephropathy (IgAN) is glomerular mesangial deposition predominantly of IgA and here, mostly of dimeric and polymeric IgA1. It has long been discussed whether the deposited IgA carries any antigenic specificity and whether this might yield clues to the pathogenesis of the disease. In this issue of JASN, Wehbi et al.1 have new insight into this question by studying affinity maturation of IgA and its relationship to mesangial IgA deposition.

In the process of affinity maturation, B cells, activated by follicular helper T cells, continuously improve the binding of their antibodies after antigen exposure, in particular on repeated exposure.1 In simple terms, affinity maturation is the consequence of two principles. First, continuous mutation of antigen binding sequences of the IgA genes, which requires the DNA editing enzyme activation-induced cytidine deaminase (AID), generates antibodies with new binding specificity and affinity. Second, another principle then is “selection of the fittest” B cells, in which the many B cell clones must compete for help from the follicular helper T cells. These T cells present antigen to the B cells, and only those clones with high-affinity antibodies to the antigen receive signals that favor their survival, whereas low-affinity B cells are deleted.

In their study, Wehbi et al.1 used transgenic mice overexpressing human IgA1. In the presence of AID (i.e., in mice with preserved affinity maturation), mesangial IgA and complement C3 deposits as well as mild mesangioproliferative disease developed with age. No proteinuria, hematuria, or renal failure was noted. In the absence of AID, mice expressed human IgA1 carrying nonmutated, nonaffinity maturated variable domains. In these mice compared with AID wild-type mice, mesangial IgA and C3 deposits increased as did mesangial expansion. Renal failure developed, but again, it was in the absence of significant proteinuria or hematuria. The authors conclude that IgA-related nephrotoxicity involves IgA produced by innate-like B cells rather than high-affinity maturated IgA antibodies.

Although indeed, polymeric IgA may exhibit different capacities to inflict glomerular damage depending on affinity maturation, the alternative hypothesis is that glomerular damage is a function of the abundance of polymeric IgA. Thus, in the mice with present AID, IgA levels in serum increased four- to sevenfold with age, whereas serum IgA levels increased by about 50-fold in AID-deficient mice.1 This study thereby extends a number of mouse models of glomerular IgA deposition and variable degrees of renal damage (Table 1). All of these, when examined, exhibited moderately to massively elevated IgA serum levels, much higher than the mild about twofold elevation in serum IgA that is observed in about one half of patients with IgAN.2

View this table:
  • View inline
  • View popup
Table 1.

Mouse models with an IgA nephropathy–like disease manifestation

Another important observation in the study of Wehbi et al.1 is that serum IgA, even in the mice with pronounced renal damage, did not exhibit an altered glycosylation, in particular reduced galactosylation. In human primary IgAN, most mesangial IgA1 exhibits an undergalactosylated hinge region.3 This galactose-deficient IgA is now believed to be a major contributor to the pathogenesis of IgAN, although its serum levels are only mildly elevated and normal in about 50% of patients with IgAN.4 The IgA1 hinge region is unique to humans and higher monkeys, and even small monkeys, like the Brazilian marmoset, no longer have a hinge-containing IgA molecule. In addition to other differences in the IgA system, this has severely hampered the development of good preclinical models of human IgAN. Therefore, the remarkable observation in the study of Wehbi et al.1 is that human IgA1 without any obvious glycation defect can induce glomerular damage as long as serum levels are high enough or it is not affinity maturated. Similarly, a second important observation in that study is that human IgA1 induced glomerular damage independent of CD89, a presumed IgA receptor.5 In a previous study, human CD89 overexpression on macrophages/monocytes as opposed to neutrophils in the work by Wehbi et al.1 induced overt disease with hematuria and proteinuria in mice transgenic for human IgA1.5

Therefore, my conclusion from all of these data is that markedly elevated human or murine polymeric IgA in serum can induce glomerular IgA deposits in mice, a case of “fatal attraction.” If the same is true in humans, it could explain why glomerular IgA deposits have been detected in 5% of random German autopsies6 and 15% of Japanese donor kidneys before transplantation,7 even in the absence of any known cause of secondary IgAN.8 What requires more systematic study is the relative contribution of elevated polymeric serum IgA versus particular features, in particular galactosylation patterns, of circulating IgA in inducing IgAN or an IgAN-like disease. Thus, Table 1 shows that experimental IgA-associated glomerular damage can develop without hematuria, an almost universal finding in human primary IgAN, or proteinuria, and in particular, only rare models seem to lead to ESRD. In addition, in the study of Wehbi et al.1 as in several other studies, no electron microscopy was performed, and we are left to speculate whether the glomerular localization of IgA or IgA complexes, be it mesangial or capillary, affects disease manifestations, such as hematuria or proteinuria. Indeed, in a previous study,5 mice overexpressing human IgA1 only had endocapillary IgA1 deposits but did not have mesangial injury or kidney dysfunction, and only sCD89 coinjection or coexpression induced mesangial IgA1 deposits, hematuria, and proteinuria.

A final good illustration of why we need to better understand the “fatal attraction” of IgA for the mesangium is liver disease: IgAN is detected in 9%–25% of patients receiving a kidney biopsy at the time of a liver transplantation, and patients with liver cirrhosis exhibit two- to fourfold increases in serum IgA levels, including elevated polymeric IgA and undergalactosylated IgA.8 However, in contrast to primary IgAN, the mesangial IgA deposits in liver cirrhosis did not stain with an antibody specific for the galactose-deficient IgA1 hinge region,3 mesangial proliferation is less prominent, and serum IgA1 from patients with liver cirrhosis was less potent in inducing proliferation of human mesangial cells in vitro.8 All of the above are calls for efforts to identify subtypes of what we collectively call IgAN. Better understanding of these different pathomechanisms may allow us to clarify why patients have radically different clinical courses ranging from inert glomerular IgA deposits with little or no clinical manifestations to rapidly progressive IgAN quickly resulting in ESRD.

Disclosures

None.

Footnotes

  • Published online ahead of print. Publication date available at www.jasn.org.

  • See related article, “Mesangial Deposition Can Strongly Involve Innate-Like IgA Molecules Lacking Affinity Maturation,” on pages 1238–1249.

  • Copyright © 2019 by JASN

References

  1. ↵
    1. Wehbi B,
    2. Oblet C,
    3. Boyer F,
    4. Huard B,
    5. Druilhe A,
    6. Paraf F, et al
    .: Mesangial deposition can strongly involve innate-like IgA molecules lacking affinity maturation. J Am Soc Nephrol 30: 1238–1249, 2019
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. van der Boog PJ,
    2. van Kooten C,
    3. de Fijter JW,
    4. Daha MR
    : Role of macromolecular IgA in IgA nephropathy. Kidney Int 67: 813–821, 2005
    OpenUrlCrossRefPubMed
  3. ↵
    1. Suzuki H,
    2. Yasutake J,
    3. Makita Y,
    4. Tanbo Y,
    5. Yamasaki K,
    6. Sofue T, et al
    .: IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis. Kidney Int 93: 700–705, 2018
    OpenUrl
  4. ↵
    1. Yasutake J,
    2. Suzuki Y,
    3. Suzuki H,
    4. Hiura N,
    5. Yanagawa H,
    6. Makita Y, et al
    .: Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy. Nephrol Dial Transplant 30: 1315–1321, 2015
    OpenUrlCrossRefPubMed
  5. ↵
    1. Berthelot L,
    2. Papista C,
    3. Maciel TT,
    4. Biarnes-Pelicot M,
    5. Tissandie E,
    6. Wang PH, et al
    .: Transglutaminase is essential for IgA nephropathy development acting through IgA receptors. J Exp Med 209: 793–806, 2012
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Waldherr R,
    2. Rambausek M,
    3. Duncker WD,
    4. Ritz E
    : Frequency of mesangial IgA deposits in a non-selected autopsy series. Nephrol Dial Transplant 4: 943–946, 1989
    OpenUrlPubMed
  7. ↵
    1. Suzuki K,
    2. Honda K,
    3. Tanabe K,
    4. Toma H,
    5. Nihei H,
    6. Yamaguchi Y
    : Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int 63: 2286–2294, 2003
    OpenUrlCrossRefPubMed
  8. ↵
    1. Saha MK,
    2. Julian BA,
    3. Novak J,
    4. Rizk DV
    : Secondary IgA nephropathy. Kidney Int 94: 674–681, 2018
    OpenUrl
    1. Suzuki H,
    2. Suzuki Y
    : Murine models of human IgA nephropathy. Semin Nephrol 38: 513–520, 2018
    OpenUrl
PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 30 (7)
Journal of the American Society of Nephrology
Vol. 30, Issue 7
July 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
Fatal Attraction: Immunoglobulin A and the Glomerular Mesangium
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Fatal Attraction: Immunoglobulin A and the Glomerular Mesangium
Jürgen Floege
JASN Jul 2019, 30 (7) 1139-1141; DOI: 10.1681/ASN.2019040373

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Fatal Attraction: Immunoglobulin A and the Glomerular Mesangium
Jürgen Floege
JASN Jul 2019, 30 (7) 1139-1141; DOI: 10.1681/ASN.2019040373
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Disclosures
    • Footnotes
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

Up Front Matters

  • The Mineralocorticoid Receptor in Salt-Sensitive Hypertension and Renal Injury
  • Missing Self and DSA—Synergy of Two NK Cell Activation Pathways in Kidney Transplantation
  • The Road Ahead for Research on Air Pollution and Kidney Disease
Show more Up Front Matters

Editorials

  • The Mineralocorticoid Receptor in Salt-Sensitive Hypertension and Renal Injury
  • Missing Self and DSA—Synergy of Two NK Cell Activation Pathways in Kidney Transplantation
  • The Road Ahead for Research on Air Pollution and Kidney Disease
Show more Editorials

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Related Articles

  • Mesangial Deposition Can Strongly Involve Innate-Like IgA Molecules Lacking Affinity Maturation
  • PubMed
  • Google Scholar

Keywords

  • IgA nephropathy
  • proteinuria
  • Progression
  • GFR loss
  • Innate immunity
  • Affinity maturation

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire